Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.31 USD | -3.43% | -50.44% | -57.21% |
Jun. 04 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
May. 31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-57.21% | 1.79B | |
+18.11% | 125B | |
+13.88% | 109B | |
-3.33% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.10% | 16.64B | |
0.00% | 13.45B | |
+21.89% | 11.32B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Sanofi to Acquire Inhibrx for Up to $2.2 Billion